Cargando…
Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy
BACKGROUND: Compliance, palatability, gastrointestinal (GI) symptom, and treatment satisfaction patient- and observer-reported outcome (PRO, ObsRO) measures were developed/modified for patients with transfusion-dependent anemias or myelodysplastic syndrome (MDS) requiring iron chelation therapy (ICT...
Autores principales: | Horodniceanu, Erica G., Bal, Vasudha, Dhatt, Harman, Carter, John A., Huang, Vicky, Lasch, Kathryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481883/ https://www.ncbi.nlm.nih.gov/pubmed/28645270 http://dx.doi.org/10.1186/s12955-017-0702-0 |
Ejemplares similares
-
Therapeutic Potential of Iron Chelating Therapy: Modification of
Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994) -
Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003) -
Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009) -
Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010) -
Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)